Immunological evidence for functional rather than structural mimicry by a Shigella flexneri Y polysaccharide-mimetic

Silvia Borrelli1, Rehana B Hossany, B Mario Pinto

  • 1Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada.

Insights

This study shows that a peptide mimic (MDWNMHAA) of Shigella flexneri Y O polysaccharide successfully elicits antibodies. These antibodies cross-react with the target polysaccharide, supporting functional mimicry for vaccine development.

Area of Science:

  • Immunology
  • Vaccine Design
  • Microbial Pathogenesis

Background:

  • Vaccine development often employs molecular mimics of pathogenic antigens.
  • A peptide mimic, MDWNMHAA, of Shigella flexneri Y O polysaccharide (PS) was previously studied.
  • X-ray crystallography suggested functional rather than structural mimicry by MDWNMHAA.

Purpose of the Study:

  • To investigate the antibody response elicited by a conjugate of MDWNMHAA and tetanus toxoid (TT) in mice.
  • To assess the immunological cross-reactivity between the peptide mimic and the native polysaccharide.

Main Methods:

  • BALB/c mice were immunized with MDWNMHAA-TT conjugate using a homologous prime/boost strategy.
  • Antibody titers (IgG) against peptide and lipopolysaccharide (LPS) were measured.
  • Inhibition enzyme-linked immunosorbent assays were used to assess antibody binding specificity.

Main Results:

  • Immunization with MDWNMHAA-TT induced significant anti-peptide and anti-LPS IgG titers.
  • A conjugate with increased peptide density accelerated the immune response and cross-reactivity.
  • Antibodies generated against the peptide also bound to LPS, and this binding was inhibited by LPS, PS, and the peptide.

Conclusions:

  • The study supports functional mimicry of S. flexneri Y O PS by MDWNMHAA.
  • Underrepresentation of bound conformation in free-ligand ensemble did not impede immunological cross-reactivity.
  • Optimized prime/boost strategies with peptide conjugates can lead to high anti-LPS titers, confirming antigenic mimicry.